1. Home
  2. SCL vs GLUE Comparison

SCL vs GLUE Comparison

Compare SCL & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$50.63

Market Cap

1.1B

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$25.14

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCL
GLUE
Founded
1932
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SCL
GLUE
Price
$50.63
$25.14
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$19.50
AVG Volume (30 Days)
154.8K
2.3M
Earning Date
02-18-2026
11-06-2025
Dividend Yield
3.16%
N/A
EPS Growth
N/A
N/A
EPS
1.98
0.25
Revenue
$2,303,837,000.00
$181,538,000.00
Revenue This Year
$8.79
$84.02
Revenue Next Year
$8.14
N/A
P/E Ratio
$25.28
$92.23
Revenue Growth
5.35
1112.27
52 Week Low
$41.82
$3.50
52 Week High
$65.89
$25.15

Technical Indicators

Market Signals
Indicator
SCL
GLUE
Relative Strength Index (RSI) 73.52 75.70
Support Level $46.70 $13.69
Resistance Level $47.77 $17.81
Average True Range (ATR) 1.13 1.58
MACD 0.23 0.64
Stochastic Oscillator 86.87 95.28

Price Performance

Historical Comparison
SCL
GLUE

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: